Balancing risks and benefits in the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer

被引:0
作者
Unsworth-White, Samantha [1 ]
Humayun-Zakaria, Nada [2 ,3 ]
Bryan, Richard T. [3 ]
机构
[1] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, England
[3] Univ Birmingham, Bladder Canc Res Ctr, Birmingham B15 2TT, England
关键词
Atezolizumab; circulating-tumour DNA (ctDNA); non-muscle-invasive bladder cancer (NMIBC); Bacillus Calmette-Guerin-unresponsive (BCG-unresponsive); immuno-oncology; OPEN-LABEL; ATEZOLIZUMAB; MULTICENTER; BCG;
D O I
10.21037/tau-24-529
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [21] Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin- unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605
    Black, Peter C.
    Tangen, Catherine M.
    Singh, Parminder
    McConkey, David J.
    Lucia, M. Scott
    Lowrance, William T.
    Koshkin, Vadim S.
    Stratton, Kelly L.
    Bivalacqua, Trinity J.
    Kassouf, Wassim
    Porten, Sima P.
    Bangs, Rick
    Plets, Melissa
    Thompson, Ian M.
    Lerner, Seth P.
    EUROPEAN UROLOGY, 2023, 84 (06) : 536 - 544
  • [22] An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancer
    Khene, Zine-Eddine
    Lotan, Yair
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (06) : 415 - 423
  • [23] Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guerin
    de Jong, Florus C.
    Laajala, Teemu D.
    Hoedemaeker, Robert F.
    Jordan, Kimberley R.
    van der Made, Angelique C. J.
    Boeve, Egbert R.
    van der Schoot, Deric K. E.
    Nieuwkamer, Bart
    Janssen, Emiel A. M.
    Mahmoudi, Tokameh
    Boormans, Joost L.
    Theodorescu, Dan
    Costello, James C.
    Zuiverloon, Tahlita C. M.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (697)
  • [24] Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer
    Shepherd, Andrew R. H.
    Shepherd, Emily
    Brook, Nicholas R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [25] Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
    Hannouneh, Zein Alabdin
    Hijazi, Amjad
    Alsaleem, Alaa Aldeen
    Hami, Siwan
    Kheyrbek, Nina
    Tanous, Fadi
    Khaddour, Karam
    Abbas, Abdulfattah
    Alshehabi, Zuheir
    CANCER MEDICINE, 2023, 12 (24): : 21944 - 21968
  • [26] Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart Review
    Kulkarni, Girish S.
    Guzzo, Thomas
    Abbosh, Philip H.
    Huang, William C.
    Shore, Neal
    Smith, Zachary
    Seo, Ho Kyung
    Ku, Ja Hyeon
    Paradis, Jean-Benoit
    Mathieu, Romain
    Roumiguie, Mathieu
    Srivastava, Abhishek
    Rodriguez, Carly
    Fox, Claire M.
    Kapadia, Ekta
    Burcu, Mehmet
    Boormans, Joost L.
    CLINICAL GENITOURINARY CANCER, 2025, 23 (03)
  • [27] The Management of Bacillus Calmette-Guerin (BCG) Failure in High-Risk Non-muscle Invasive Bladder Cancer: A Review Article
    Kodera, Ahmed
    Mohammed, Mahmoud
    Lim, Paul
    Abdalla, Omer
    Elhadi, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [28] Intravesical Bacillus Calmette-Guerin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder Cancer
    Kim, Joseph I.
    Zhu, Denzel
    Barry, Emily
    Kovac, Evan
    Aboumohamed, Ahmed
    Agalliu, Ilir
    Sankin, Alex
    CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : E409 - E416
  • [29] Efficacy and tolerability of bacillus Calmette-Guerin strain Russia for the treatment of non-muscle-invasive bladder cancer: Analysis of a prospective registry
    Flury-Sutter, Sarah
    Heuzeroth, Frederick
    Arbelaez, Emilio
    Bubendorf, Lukas
    Puschel, Heike
    Hayoz, Stefanie
    Rentsch, Cyrill A.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2024, 18 (07): : E233 - E239
  • [30] Salvage Therapies for Non-muscle-invasive Bladder Cancer: Who Will Respond to Bacillus Calmette-Guerin? Predictors and Nomograms
    Faba, Oscar Rodriguez
    Pisano, Francesca
    Krajewski, Wojciech
    Breda, Alberto
    Palou, Joan
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (01) : 5 - 13